Angela Manuela Ribeiro De Carvalho

Title: Angela Manuela Ribeiro De Carvalho: Innovator in Biotech

Introduction

Angela Manuela Ribeiro De Carvalho is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of biotechnology, particularly in the area of opioid production. Her innovative work has led to the development of a patented process that enhances the accessibility of important chemical compounds.

Latest Patents

Angela holds a patent for the "Demethylation of reticuline and derivatives thereof with fungal cytochrome P450." This invention involves recombinant host cells that express genes encoding a cytochrome P450 enzyme capable of N-demethylating and/or O-demethylating reticuline and its derivatives. The methods outlined in her patent provide a means to cultivate these recombinant hosts in a culture medium, facilitating the production of N-demethylated and/or O-demethylated reticuline. This advancement is crucial for obtaining naturally unavailable and chemically challenging starting materials for opioids.

Career Highlights

Angela is currently associated with River Stone Biotech LLC, where she continues to push the boundaries of biotechnological research. Her work is characterized by a commitment to innovation and the development of practical applications for her discoveries.

Collaborations

Angela collaborates with talented individuals in her field, including Markus Schwab and Sumire Honda Malca. These partnerships enhance her research and contribute to the advancement of biotechnology.

Conclusion

Angela Manuela Ribeiro De Carvalho is a trailblazer in the biotech industry, with a focus on innovative solutions for opioid production. Her contributions through her patent and collaborations highlight her role as a key figure in advancing biotechnological research.